The Non-Opioids Prevent Addiction in the Nation Act (NOPAIN Act), which took effect on January 1, 2025, is influencing ...

A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Add Yahoo as a preferred source to see more of our stories on Google. A pharmacist at Mayo Pharmacy in Bismarck, N.D., reviews completed pharmaceutical orders in January. Advocates, providers, medical ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists. The ...

Add Yahoo as a preferred source to see more of our stories on Google. The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say Journavx is ...

More states are requiring their Medicaid programs and health insurance companies to cover non-opioid pain medications as an alternative to opioids, which can be cheaper for insurers but also more ...

NEW ORLEANS — It's the first new type of painkiller in 20 years. And it's just a few weeks away from being in local pharmacies. Here are some details from a neurosurgeon about what you can expect from ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

The American Society of Anesthesiologists is urging CMS not to proceed with proposed policies that would end coverage of peripheral nerve blocks for chronic pain. ASA applauded 25 bipartisan members ...